HLL joins hands with U.S. firm to launch iBreastExam device

July 01, 2023 08:41 pm | Updated 08:41 pm IST - Thiruvananthapuram

HLL Lifecare Ltd., a Union government ‘Mini Ratna’ public sector enterprise, has joined hands with UE LifeSciences, a women’s health innovator based in the U.S., to combat high mortality rates associated with breast cancer by introducing ‘iBreastExam,’ a device for early detection.

India witnesses more breast cancer-related deaths than any other country, with a significant number of women under the age of 50 succumbing to the disease, as per the Global Cancer Observatory study. The majority of cases are detected at a later stage, resulting in poor survival rates.

To find an innovative solution to this, HLL has empanelled UE LifeSciences for five years to bring iBreastExam to the forefront.

iBreastExam offers a standardised process for clinical breast examination, eliminating variabilities in the process. Given the challenges associated with mammogram screening in low-resource settings, the device serves as a practical alternative.

Clinically validated through independent studies involving over 25,000 women, iBreastExam incorporates ‘dynamic co-planar capacitive sensor technology’ to measure the differences in tissue elasticity in real-time at the point of care and without requiring manual interpretation. It helps in identifying and triaging for clinically relevant breast lumps in healthy, asymptomatic women.

Being hand-held, non-invasive and radiation-free, it helps to bring early detection to women in the communities where they live and work. iBreastExam also facilitates seamless patient follow-up by securely storing data on the cloud.

The device is designed for use by frontline health workers, nurses, primary care doctors and NGOs operating in the area of women’s health.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.